Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue and Organ Procurement | 16 | 2025 | 321 | 4.850 |
Why?
|
| Perfusion | 13 | 2025 | 214 | 4.300 |
Why?
|
| Heart Transplantation | 15 | 2025 | 755 | 3.700 |
Why?
|
| Organ Preservation | 12 | 2025 | 102 | 3.560 |
Why?
|
| Tissue Donors | 17 | 2025 | 425 | 2.700 |
Why?
|
| Lung Transplantation | 5 | 2025 | 313 | 1.280 |
Why?
|
| Primary Graft Dysfunction | 2 | 2025 | 32 | 1.060 |
Why?
|
| Waiting Lists | 3 | 2025 | 262 | 1.010 |
Why?
|
| Lichens | 2 | 2023 | 15 | 0.980 |
Why?
|
| Consensus | 3 | 2024 | 683 | 0.920 |
Why?
|
| Organ Preservation Solutions | 1 | 2023 | 45 | 0.840 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2024 | 70 | 0.830 |
Why?
|
| Transplant Recipients | 1 | 2025 | 184 | 0.820 |
Why?
|
| Genome, Mitochondrial | 1 | 2023 | 27 | 0.790 |
Why?
|
| Terminology as Topic | 1 | 2024 | 216 | 0.780 |
Why?
|
| Cold Ischemia | 1 | 2021 | 30 | 0.700 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2024 | 529 | 0.680 |
Why?
|
| Registries | 5 | 2025 | 2037 | 0.650 |
Why?
|
| Graft Rejection | 3 | 2025 | 624 | 0.620 |
Why?
|
| Heart Failure | 5 | 2025 | 2237 | 0.590 |
Why?
|
| Vascular Stiffness | 1 | 2023 | 496 | 0.580 |
Why?
|
| Organ Transplantation | 4 | 2024 | 250 | 0.570 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 56 | 0.470 |
Why?
|
| Graft Survival | 5 | 2025 | 536 | 0.450 |
Why?
|
| Ventricular Dysfunction, Right | 3 | 2022 | 238 | 0.440 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2022 | 301 | 0.440 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 267 | 0.410 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 249 | 0.400 |
Why?
|
| Humans | 42 | 2025 | 137621 | 0.400 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 278 | 0.390 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 1910 | 0.370 |
Why?
|
| Stents | 1 | 2016 | 527 | 0.360 |
Why?
|
| Ventricular Function, Right | 3 | 2023 | 285 | 0.350 |
Why?
|
| Heart Ventricles | 4 | 2021 | 790 | 0.350 |
Why?
|
| Surgeons | 3 | 2025 | 291 | 0.350 |
Why?
|
| Adult | 16 | 2025 | 37947 | 0.340 |
Why?
|
| Retrospective Studies | 12 | 2025 | 15620 | 0.320 |
Why?
|
| Rectal Neoplasms | 1 | 2009 | 149 | 0.280 |
Why?
|
| Rectum | 1 | 2009 | 185 | 0.280 |
Why?
|
| Death | 3 | 2024 | 119 | 0.270 |
Why?
|
| Carcinoma | 1 | 2009 | 229 | 0.270 |
Why?
|
| Brain Death | 2 | 2024 | 46 | 0.260 |
Why?
|
| Survival Analysis | 3 | 2021 | 1315 | 0.260 |
Why?
|
| Middle Aged | 14 | 2025 | 33465 | 0.240 |
Why?
|
| Heart-Assist Devices | 2 | 2021 | 554 | 0.230 |
Why?
|
| ABO Blood-Group System | 1 | 2025 | 51 | 0.230 |
Why?
|
| Resource Allocation | 1 | 2025 | 52 | 0.220 |
Why?
|
| Time Factors | 3 | 2025 | 6831 | 0.220 |
Why?
|
| Intraoperative Complications | 1 | 2025 | 138 | 0.210 |
Why?
|
| Donor Selection | 1 | 2024 | 77 | 0.210 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 5122 | 0.210 |
Why?
|
| Synteny | 1 | 2023 | 15 | 0.200 |
Why?
|
| Costs and Cost Analysis | 1 | 2024 | 213 | 0.200 |
Why?
|
| Allografts | 1 | 2023 | 145 | 0.200 |
Why?
|
| Shock | 1 | 2024 | 98 | 0.200 |
Why?
|
| Cardiac Catheterization | 2 | 2023 | 530 | 0.200 |
Why?
|
| Benzofurans | 1 | 2022 | 21 | 0.190 |
Why?
|
| Ascomycota | 1 | 2022 | 31 | 0.190 |
Why?
|
| Heart-Lung Transplantation | 1 | 2022 | 14 | 0.190 |
Why?
|
| Male | 13 | 2025 | 67800 | 0.180 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 114 | 0.180 |
Why?
|
| Prostatic Neoplasms | 1 | 2009 | 1040 | 0.180 |
Why?
|
| Hepatitis C | 1 | 2023 | 271 | 0.170 |
Why?
|
| Pulmonary Artery | 2 | 2023 | 1088 | 0.170 |
Why?
|
| Cardiac Output | 1 | 2020 | 172 | 0.160 |
Why?
|
| Female | 12 | 2025 | 73365 | 0.160 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2019 | 25 | 0.160 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2019 | 32 | 0.160 |
Why?
|
| Myocardial Contraction | 1 | 2020 | 341 | 0.150 |
Why?
|
| CpG Islands | 1 | 2019 | 157 | 0.150 |
Why?
|
| Phylogeny | 1 | 2023 | 904 | 0.150 |
Why?
|
| Biological Evolution | 1 | 2023 | 475 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 362 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2019 | 71 | 0.150 |
Why?
|
| Glucose | 1 | 2023 | 1020 | 0.150 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 318 | 0.150 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 153 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2023 | 2040 | 0.140 |
Why?
|
| Heart Atria | 1 | 2019 | 137 | 0.140 |
Why?
|
| United States | 9 | 2025 | 14869 | 0.140 |
Why?
|
| Liver Transplantation | 1 | 2025 | 871 | 0.140 |
Why?
|
| Spontaneous Perforation | 1 | 2016 | 2 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2024 | 10823 | 0.130 |
Why?
|
| Prognosis | 3 | 2025 | 4009 | 0.130 |
Why?
|
| Survival Rate | 3 | 2025 | 1956 | 0.120 |
Why?
|
| Aortography | 1 | 2016 | 52 | 0.120 |
Why?
|
| Vena Cava Filters | 1 | 2016 | 61 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 787 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 709 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1251 | 0.110 |
Why?
|
| Heart | 3 | 2023 | 655 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2019 | 643 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2016 | 202 | 0.100 |
Why?
|
| Adolescent | 2 | 2023 | 21560 | 0.100 |
Why?
|
| Trauma Centers | 1 | 2016 | 421 | 0.100 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 279 | 0.100 |
Why?
|
| Insulin | 1 | 2023 | 2411 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2680 | 0.100 |
Why?
|
| Hemostatic Techniques | 1 | 2012 | 46 | 0.090 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 100 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2016 | 312 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3573 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2023 | 3458 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2016 | 910 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 2111 | 0.080 |
Why?
|
| Resuscitation | 1 | 2012 | 251 | 0.080 |
Why?
|
| Pelvic Exenteration | 1 | 2009 | 11 | 0.080 |
Why?
|
| Exercise | 1 | 2020 | 2063 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2012 | 722 | 0.070 |
Why?
|
| Aged | 2 | 2024 | 23924 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 509 | 0.070 |
Why?
|
| Stroke Volume | 2 | 2020 | 617 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2009 | 245 | 0.060 |
Why?
|
| Biopsy | 1 | 2009 | 1125 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2016 | 5725 | 0.060 |
Why?
|
| Young Adult | 1 | 2021 | 13226 | 0.060 |
Why?
|
| United Kingdom | 1 | 2025 | 318 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2024 | 71 | 0.050 |
Why?
|
| Polyketide Synthases | 1 | 2022 | 5 | 0.050 |
Why?
|
| Travel | 1 | 2023 | 130 | 0.050 |
Why?
|
| Multigene Family | 1 | 2022 | 197 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 63 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2023 | 261 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2023 | 317 | 0.040 |
Why?
|
| Child | 1 | 2021 | 21985 | 0.040 |
Why?
|
| Drainage | 1 | 2022 | 173 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 433 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 426 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 10401 | 0.040 |
Why?
|
| Methylation | 1 | 2019 | 229 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2019 | 96 | 0.040 |
Why?
|
| Critical Care | 1 | 2024 | 611 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 245 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2023 | 642 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1477 | 0.040 |
Why?
|
| Exercise Test | 1 | 2020 | 632 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2020 | 629 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 698 | 0.030 |
Why?
|
| Lysine | 1 | 2019 | 294 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2019 | 209 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 415 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 947 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 2181 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2022 | 1789 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 637 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2845 | 0.030 |
Why?
|
| Liver | 1 | 2022 | 1943 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 2225 | 0.030 |
Why?
|
| Plasma Substitutes | 1 | 2012 | 3 | 0.020 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 2012 | 8 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 2012 | 38 | 0.020 |
Why?
|
| Pandemics | 1 | 2021 | 1622 | 0.020 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2012 | 41 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 5797 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1993 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2023 | 2655 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2012 | 147 | 0.020 |
Why?
|
| Plasma | 1 | 2012 | 212 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2012 | 194 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 849 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 3956 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2012 | 1112 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 1209 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2012 | 832 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 3567 | 0.010 |
Why?
|